Trials / Completed
CompletedNCT06745492
Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Low-dose Neostigmine at TOF Ratio of 0.7 Accelerates Neuromuscular Recovery Without Adverse Effects: a Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective observational study. A total of 54 patients were included in this study. We observed the time from neostigmine administration to TOF ratio of 1.0.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neostigmine + Glycopyrrolate | a 20 mcg/kg of neostigmine and 4 mcg/kg of glycopyrrolate were administered at a TOF ratio of 0.7. |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-08-20
- Completion
- 2023-08-25
- First posted
- 2024-12-20
- Last updated
- 2024-12-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06745492. Inclusion in this directory is not an endorsement.